Quick Diagnostic Program for Head and Neck Cancer
NCT02030509 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 196
Last updated 2016-08-09
Summary
Head and neck cancer would be suitable for quick diagnostic programs because their initial symptoms are easy detectable and the curation rates in the initial stages are very high.
Actually the stages at diagnosis are about 30% in initial stages and 70% in advanced stages.
The hypothesis of this study is that a program for quick referral of patients with symptoms of head and neck cancer would help early diagnosis.
Conditions
- Cancer of Head and Neck
Interventions
- OTHER
-
Quick diagnosis program
Sponsors & Collaborators
-
Corporacion Parc Tauli
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-02-28
- Primary Completion
- 2016-02-29
- Completion
- 2016-05-31
Countries
- Spain
Study Locations
More Related Trials
-
Head and Neck Early Relapse Detection Study (HERD)
NCT05097625 ·Status: RECRUITING
-
Circulating Tumor Cells as an Early Predictive head-and -Neck Squamous-cell Carcinoma
NCT02119559 ·Status: UNKNOWN ·Phase: NA
-
Definitive Chemo-Radiotherapy for Regionally Advanced Head and Neck Cancer With or Without Up-front Neck Dissection
NCT02918955 ·Status: COMPLETED ·Phase: PHASE3
-
Anti-tumor Specific Immune Response in Head and Neck Cancers
NCT02881918 ·Status: UNKNOWN
-
Radiation and Cetuximab Plus Intratumoral EGFR Antisense DNA in Locally Advanced Head and Neck Squamous Cell Carcinoma
NCT01592721 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Studying Survivorship Care Plans in Head and Neck Cancer
NCT03106090 ·Status: TERMINATED ·Phase: NA
-
Use of Computer-based Patient-reported Data to Assess Long Term and Late Effects of Head and Neck Cancer at the Point-of-care
NCT01803061 ·Status: COMPLETED ·Phase: NA
-
Reconstructive Surgery For Head And Neck Cancer Patients
NCT00578032 ·Status: COMPLETED
-
Acute and Long-term Impact of Cancer Treatment on Head and Neck Cancer Patients: FIT4TREATMENT
NCT04996147 ·Status: TERMINATED
-
The Clinical Study of the Poorly Differentiated Head and Neck Squamous Cell Carcinoma
NCT02916368 ·Status: UNKNOWN
-
Assessing Tumor Response and IMRT Treat Plan After IC Based on FDG-PET/CT for Locally Advanced HNSCC
NCT02047201 ·Status: COMPLETED ·Phase: PHASE2
-
H&N Cancer; Survivorship and Late Effects
NCT04758026 ·Status: COMPLETED
-
EVEREST-HN 1: EVolution of a patiEnt-REported Symptom-based Risk Stratification sySTem
NCT05909020 ·Status: RECRUITING
-
A Prospective, Multicenter, Multicohort Phase II Study: Evaluating the Efficacy and Safety of Preoperative Neoadjuvant Treatment With a PD-1 Inhibitor in Combination With Chemotherapy in Locally Advanced Laryngeal and Hypopharyngeal Squamous Cell Carcinoma
NCT06894459 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Prognostic Value of CTC in HNSCC Patients
NCT01884129 ·Status: TERMINATED
-
The Head and Neck Registry of the European Reference Network on Rare Adult Solid Cancers
NCT05483374 ·Status: RECRUITING
-
RGD-K5 in Head and Neck Cancer Patients
NCT01447134 ·Status: UNKNOWN
-
Multicenter Phase II Study of Sentinel Node Detection in Squamous Cell Carcinoma T1-T2N0 of the Oropharynx Treated With Radiotherapy and Larynx Treated by Surgery, Laser or Robot
NCT03010553 ·Status: UNKNOWN ·Phase: PHASE2
-
Efficacy and Safety of PD-1 Plus Chemotherapy in Poorly Differentiated Locally Advanced (LA) HNSCC
NCT06100497 ·Status: RECRUITING ·Phase: PHASE2
-
Value of Geriatric Screening to Predict Postoperative Morbidity for Head and Neck Cancer
NCT03053310 ·Status: ACTIVE_NOT_RECRUITING
-
Analysis of Patterns of Recurrence in Head and Neck Cancer Using Clinicopathomic Markers
NCT04086849 ·Status: COMPLETED
-
Phase II Trial: uPAR-PET/CT for Prognostication in Head- and Neck Cancer
NCT02965001 ·Status: COMPLETED ·Phase: PHASE2
-
Identification of Predictive Factors for the Response to Anti-Programmed Cell Death Protein 1 (PD1) Immunotherapy in Head and Neck Squamous Cell Carcinoma
NCT05328024 ·Status: RECRUITING
-
Tolerability and Efficacy of UV1 Vaccine in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Planned for First-line Treatment With Pembrolizumab
NCT05075122 ·Status: UNKNOWN ·Phase: PHASE2
-
Induction Modified TPF Followed by Concurrent Chemoradiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck
NCT05527782 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2